As of 2024-12-13, the Relative Valuation of NOXXON Pharma NV (ALNOX.PA) is (2.44) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.05 EUR, the upside of NOXXON Pharma NV based on Relative Valuation is -4983.8%.
The range of the Relative Valuation is (2.23) - (2.63) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.2x - 14.7x | 13.4x |
| Forward P/E multiples | 12.2x - 14.4x | 13.3x |
| Fair Price | (2.23) - (2.63) | (2.44) |
| Upside | -4554.8% - -5358.1% | -4983.8% |
| Date | P/E |